GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Accelerator Applications SA (NAS:AAAP) » Definitions » Beta

Advanced Accelerator Applications (Advanced Accelerator Applications) Beta : N/A (As of May. 06, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Advanced Accelerator Applications Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-06), Advanced Accelerator Applications's Beta is Not available.


Advanced Accelerator Applications Beta Historical Data

The historical data trend for Advanced Accelerator Applications's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Accelerator Applications Beta Chart

Advanced Accelerator Applications Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Beta
Get a 7-Day Free Trial - - - - -

Advanced Accelerator Applications Quarterly Data
Dec11 Dec12 Dec13 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Advanced Accelerator Applications's Beta

For the Biotechnology subindustry, Advanced Accelerator Applications's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Accelerator Applications's Beta Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Accelerator Applications's Beta distribution charts can be found below:

* The bar in red indicates where Advanced Accelerator Applications's Beta falls into.



Advanced Accelerator Applications Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Advanced Accelerator Applications  (NAS:AAAP) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Advanced Accelerator Applications Beta Related Terms

Thank you for viewing the detailed overview of Advanced Accelerator Applications's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Accelerator Applications (Advanced Accelerator Applications) Business Description

Traded in Other Exchanges
N/A
Address
Advanced Accelerator Applications SA is a French-based radiopharmaceutical company. It develops, produces, and commercializes molecular nuclear medicine diagnostic and therapeutic products. The molecular nuclear medicine is a medical specialty that uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases including cancer. The company includes a portfolio of six diagnostic positron emission tomography (PET) and single-photon emission computed tomography (SPECT) products. Its PET and SPECT are imaging techniques in molecular nuclear diagnostics with applications in clinical oncology, cardiology and neurology. Its other diagnostic product is Gluscan, its branded fluorodeoxyglucose PET imaging agent.

Advanced Accelerator Applications (Advanced Accelerator Applications) Headlines